You are here

Award Data

For best search results, use the search terms first and then apply the filters

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201391 - 201400 of 204843 results
  1. SBIR Phase II: Green Solvent Mixtures as Alternatives to Environmentally Damaging and Toxic Solvents

    SBC: CCVD, Inc dba MicroCoating Technologies (MCT)            Topic: N/A

    This SBIR Phase II Project will develop software to aid formulation chemists in the replacement of environmentally damaging and toxic solvents such as those listed as hazardous air pollutants (HAP) in Section 112(b)(1) of the Clean Air Act. Phase I provided successful proof of concept for MCT's approach to use mixtures of "green" solvents that are tunable to obtain a wide range of solvent characte ...

    SBIR Phase I 2003 National Science Foundation
  2. Field-Deployable Chemical Point Detection Network

    SBC: MECHATRONIC SYSTEMS LLC            Topic: N/A

    The overall objective of this proposal is to develop a high temperature, motor drive based on silicon carbide (SiC) power semiconductors for controlling a switched reluctance motor (SRM). This motor drive will be suitable for use in either anelectromechanical actuator (EMA) or an electrohydraulic actuator (EHA). The proposed Phase II effort focus is the additional research and development needed t ...

    SBIR Phase I 2001 Department of DefenseAir Force
  3. Wavefront Coding Fluorescence Microscope

    SBC: Cdm Optics, Inc.            Topic: N/A


    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  4. Hybrid Optical/Digital Imaging for Automatic Inspection

    SBC: Cdm Optics, Inc.            Topic: N/A

    In Phase I a revolutionary system for digital imaging microscopy was demonstrated. The system is based on the newly-developed imaging technology of Wavefront Coding (WFC). WFC employs specialized aspheric optics and digital processing to greatly increasethe depth of field or depth of focus. WFC simultaneously decreases the size, weight, and cost of a variety of digital imaging systems. Depth o ...

    STTR Phase I 2001 Department of DefenseArmy
  5. N/A

    SBC: Cell Based Delivery, Inc.            Topic: N/A


    SBIR Phase I 1999 Department of Health and Human Services
  6. Development of a Protein Phosphorylation Site Database


    DESCRIPTION (provided by applicant): Protein phosphorylation is a ubiquitous mechanism that helps regulate most cellular processes including growth, differentiation, plasticity, and memory. Additionally, alterations in the regulation of phosphorylation are implicated in the etiology of many human diseases. The goal of the application is to build the Phosphosite Database (PSDB), a curated database ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  7. N/A

    SBC: Cell Therapeutics, Inc.            Topic: N/A


    STTR Phase I 1999 Department of Health and Human Services
  8. Ultralight Woven Truss and Truss-core Cellular Metal Panels


    "Ultra-lightweight high strength, high stiffness, blast-resistantstructural materials are needed for protecting naval vessels andfuture Marine Corps vehicles, such as the Marine ExpeditionaryFamily of Fighting Vehicles (MEFFV). These materials provideblast protection by plastic work which absorbs the mechanicalenergy of an impulse created by a blast. Cellular MetalsInternational (CMI) proposes to ...

    SBIR Phase I 2002 Department of DefenseNavy
  9. N/A

    SBC: CEL-SCI CORPORATION            Topic: N/A


    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health

    SBC: CENGENT THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (Adapted from the application): HER2 is a transmembrane receptor tyrosine kinase overexpressed and amplified in nearly 30 percent of cancers. It is associated with poor prognosis, chemoresistance, and aggressive and metastatic tumor growth. Herceptin, a humanized monoclonal antibody to HER2, is currently available for treatment of metastatic breast cance ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government